Covered recipient · General Payments record
AMANDA READ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$414.64
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $253.73 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $69.95 | 4 |
| ABBVIE INC. | $43.81 | 2 |
| Acerta Pharma LLC | $36.44 | 2 |
| GlaxoSmithKline, LLC. | $33.61 | 2 |
| Lilly USA, LLC | $20.16 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.93 | 1 |
| Astellas Pharma US Inc | $17.25 | 1 |
| PFIZER INC. | $14.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.99 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108066192 | CMS |
| ABBVIE INC. | $22.82 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108066194 | CMS |
| Astellas Pharma US Inc | $17.25 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139491732 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.29 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104349178 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.15 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104404297 | CMS |
| GlaxoSmithKline, LLC. | $16.35 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116224883 | CMS |
| GlaxoSmithKline, LLC. | $17.26 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116496640 | CMS |
| Lilly USA, LLC | $20.16 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135445957 | CMS |
| Novo Nordisk Inc | $19.16 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100510535 | CMS |
| Novo Nordisk Inc | $15.20 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100382029 | CMS |
| Novo Nordisk Inc | $21.52 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100250730 | CMS |
| Novo Nordisk Inc | $14.07 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100538600 | CMS |
| PFIZER INC. | $14.58 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131294045 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.93 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137812602 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.